Sensitive ASX Announcement

Imricor Commences VISABL-AFL Trial for US FDA Approval

Published: 21/06/24, 09:10am (AEST)•3 pages
Imricor Medical Systems Inc
IMR:ASX•Healthcare

Recent IMR Announcements

Price Sensitive only